Literature DB >> 3894832

Purine analogs and related nucleosides and nucleotides as antitumor agents.

R K Robins, G R Revankar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894832     DOI: 10.1002/med.2610050302

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  6 in total

1.  Increasing the therapeutic index of 5-fluorouracil and 6-thioguanine by targeting loss of MTAP in tumor cells.

Authors:  Baiqing Tang; Joseph R Testa; Warren D Kruger
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

2.  Parallel solution-phase synthesis of an adenosine antibiotic analog library.

Authors:  Omar Moukha-chafiq; Robert C Reynolds
Journal:  ACS Comb Sci       Date:  2013-02-11       Impact factor: 3.784

3.  AgNTf2-catalyzed formal [3 + 2] cycloaddition of ynamides with unprotected isoxazol-5-amines: efficient access to functionalized 5-amino-1H-pyrrole-3-carboxamide derivatives.

Authors:  Ziping Cao; Jiekun Zhu; Li Liu; Yuanling Pang; Laijin Tian; Xuejun Sun; Xin Meng
Journal:  Beilstein J Org Chem       Date:  2019-11-04       Impact factor: 2.883

4.  ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.

Authors:  Luke H Stockwin; Sherry X Yu; Howard Stotler; Melinda G Hollingshead; Dianne L Newton
Journal:  BMC Cancer       Date:  2009-02-20       Impact factor: 4.430

5.  Protein kinase C: an attractive target for cancer therapy.

Authors:  Barbara Marengo; Chiara De Ciucis; Roberta Ricciarelli; Maria A Pronzato; Umberto M Marinari; Cinzia Domenicotti
Journal:  Cancers (Basel)       Date:  2011-02-01       Impact factor: 6.639

6.  Solution-phase parallel synthesis of acyclic nucleoside libraries of purine, pyrimidine, and triazole acetamides.

Authors:  Ashish K Pathak; Vibha Pathak; Robert C Reynolds
Journal:  ACS Comb Sci       Date:  2014-06-24       Impact factor: 3.784

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.